News
19m
Regtechtimes on MSNIllumina fined $9.8M for selling DNA sequencers with cybersecurity flaws to U.S. agenciesIllumina Inc., a leading biotechnology company, has agreed to pay $9.8 million to settle allegations that it sold genomic ...
The Register on MSN14h
Gene scanner pays $9.8 million to get feds off its back in security flapIllumina allegedly lied about its testing devices meeting government standards Biotech firm Illumina has agreed to cut the US ...
Illumina introduces next generation cancer research assay, TruSight Oncology 500: San Diego Friday, August 1, 2025, 12:00 Hrs [IST] Illumina Inc., a biotechnology company develops ...
6d
Barchart on MSNWhy Cathie Wood Is Loading Up on This Hot Growth Stock (And Should You?)Image of Cathie Wood via Wikimedia Commons. In a market dominated by headlines about artificial intelligence (AI), cloud ...
Illumina posted revenues of $859m in Q120 - up 1.5% year on year, and bottom-line profits of $173m - a year-on-year decrease of 23%, whilst net profit margins also fell to just over 20%.
Illumina Inc., a global leader in DNA sequencing and array-based technologies, today announced that its first product based on its novel Illumina Complete Long Read technology is now available to ...
Given that, more companies can be expected to acquire Illumina sequencers as they work to develop their products. The second piece of good news has to do with revenue potential.
Illumina Accelerator will collaborate with Helix to support startups building direct-to-consumer genomics products. Illumina Accelerator, which is accepting applications for its seventh funding ...
The companies plan to join forces to set up pathogen monitoring programs utilizing Illumina technology across Concentric's global network. BOSTON and SAN DIEGO, Jan. 15, 2024/ PRNewswire ...
The case is Zirvi v. Illumina Inc, U.S. District Court for the District of New Jersey, No. 2:23-cv-01997. For Monib Zirvi: Joseph Garrity of Lorium Law; and Ahmed Soliman of Soliman & Associates ...
BASEL (Reuters) - Swiss drugmaker Roche Holding AG , bidding $5.7 billion for U.S. gene sequencing company Illumina , pinned its hopes on new products to drive growth this year after reporting a 4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results